Integrated Filing — IndAS



General information about company

Scrip Code 543271
NSE Symbol JUBLINGREA
MSEI Symbol NOTLISTED
ISIN INE0BY001018
Name of company JUBILANT INGREVIA LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2026
Date of end of financial year 31-03-2027
Date of board meeting when results were approved 27-10-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 14-10-2026
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Second quarter
Nature of report standalone or consolidated Consolidated
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Unaudited
Segment Reporting Multi segment
Description of single segment
Start date and time of board meeting 27-10-2026   11:10:00
End date and time of board meeting 27-10-2026   14:00:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Not applicable



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2026 01-04-2026
B Date of end of reporting period 30-09-2026 30-09-2026
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Consolidated Consolidated
1 Income
Revenue from operations 1,39,423.00 2,69,450.00
Other income 903.00 1,925.00
Total income 1,40,326.00 2,71,375.00
2 Expenses
(a) Cost of materials consumed 69,790.00 1,41,558.00
(b) Purchases of stock-in-trade 2,290.00 8,695.00
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 81.00 (15,235.00)
(d) Employee benefit expense 12,211.00 23,947.00
(e) Finance costs 2,250.00 3,993.00
(f) Depreciation, depletion and amortisation expense 5,093.00 10,194.00
(f) Other Expenses
1 Power and fuel expense 12,300.00 26,146.00
2 Others 21,510.00 43,187.00
Total other expenses 33,810.00 69,333.00
Total expenses 1,25,525.00 2,42,485.00
3 Total profit before exceptional items and tax 14,801.00 28,890.00
4 Exceptional items 0.00 0.00
5 Total profit before tax 14,801.00 28,890.00
6 Tax expense
7 Current tax 2,312.00 6,608.00
8 Deferred tax 1,343.00 551.00
9 Total tax expenses 3,655.00 7,159.00
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 11,146.00 21,731.00
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method (3.00) (6.00)
16 Total profit (loss) for period 11,143.00 21,725.00
17 Other comprehensive income net of taxes (170.00) 336.00
18 Total Comprehensive Income for the period 10,973.00 22,061.00
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent 11,143.00 21,725.00
Total profit or loss, attributable to non-controlling interests 0.00 0.00
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent 10,973.00 22,061.00
Total comprehensive income for the period attributable to owners of parent non-controlling interests 0.00 0.00
21 Details of equity share capital
Paid-up equity share capital 1,578.00 1,578.00
Face value of equity share capital 1578 1578
27 Details of debt securities
22 Reserves excluding revaluation reserve
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 7.07 13.77
Diluted earnings (loss) per share from continuing operations 7.06 13.74
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 7.07 13.77
Diluted earnings (loss) per share from continuing and discontinued operations 7.06 13.74
24 Debt equity ratio 0.2100 0.2100
25 Debt service coverage ratio 4.5600 4.6800
26 Interest service coverage ratio 9.8400 10.7900
27 Disclosure of notes on financial results



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2026
Date of end of reporting period 30-09-2026
Whether results are audited or unaudited Unaudited
Nature of report standalone or consolidated Consolidated
Assets
1 Non-current assets
Property, plant and equipment 3,12,352.00
Capital work-in-progress 28,057.00
Investment property
Goodwill 613.00
Other intangible assets 2,718.00
Intangible assets under development
Biological assets other than bearer plants
Investments accounted for using equity method 685.00
Non-current financial assets
Non-current investments 3,035.00
Trade receivables, non-current
Loans, non-current 34.00
Other non-current financial assets
1 Other financial assets 4,145.00
Total of other non-current financial assets 4,145.00
Total non-current financial assets 7,214.00
Deferred tax assets (net) 1,374.00
Other non-current assets
1 Income-tax assets (net) 821.00
2 Other non-current assets 2,109.00
Total of other non-current assets 2,930.00
Total non-current assets 3,55,943.00
2 Current assets
Inventories 1,08,365.00
Current financial asset
Current investments 0.00
Trade receivables, current 90,803.00
Cash and cash equivalents 20,069.00
Bank balance other than cash and cash equivalents 150.00
Loans, current 33.00
Other current financial assets
Total of other current financial assets 3,950.00
Total current financial assets 1,15,005.00
Current tax assets (net)
Other current assets
1 Other current assets 20,590.00
Total of other current assets 20,590.00
Total current assets 2,43,960.00
3 Non-current assets classified as held for sale 0.00
4 Regulatory deferral account debit balances and related deferred tax Assets 0.00
Total assets 5,99,903.00
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 1,578.00
Other equity 3,30,062.00
Total equity attributable to owners of parent 3,31,640.00
Non controlling interest
Total equity 3,31,640.00
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 25,269.00
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises
Total Trade payable
Other non-current financial liabilities
1 Other financial liabilities 12,638.00
Total of other non-current financial liabilities 12,638.00
Total non-current financial liabilities 37,907.00
Provisions, non-current 8,131.00
Deferred tax liabilities (net) 24,451.00
Deferred government grants, Non-current 0.00
Other non-current liabilities
Total of other non-current liabilities
Total non-current liabilities 70,489.00
Current liabilities
Current financial liabilities
Borrowings, current 64,261.00
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 8,973.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 1,00,748.00
Total Trade payable 1,09,721.00
Other current financial liabilities
1 Other financial liabilities 15,919.00
Total of other current financial liabilities 15,919.00
Total current financial liabilities 1,89,901.00
Other current liabilities 2,740.00
1 Other current liabilities 2,740.00
Total of other current liabilities 2,740.00
Provisions, current 2,472.00
Current tax liabilities (Net) 2,661.00
Deferred government grants, Current 0.00
Total current liabilities 1,97,774.00
3 Liabilities directly associated with assets in disposal group classified as held for sale 0.00
4 Regulatory deferral account credit balances and related deferred tax liability 0.00
Total liabilities 2,68,263.00
Total equity and liabilites 5,99,903.00
Disclosure of notes on assets and liabilities



Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-07-2026 01-04-2026
Date of end of reporting period 30-09-2026 30-09-2026
Whether results are audited or unaudited Unaudited Unaudited
Nature of report standalone or consolidated Consolidated Consolidated
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
1 Speciality Chemicals 68,116.00 1,31,816.00
2 Nutrition & Health Solutions 27,070.00 51,452.00
3 Chemical Intermediates 56,519.00 1,09,036.00
Total Segment Revenue 1,51,705.00 2,92,304.00
Less: Inter segment revenue 12,282.00 22,854.00
Revenue from operations 1,39,423.00 2,69,450.00
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
1 Speciality Chemicals 11,022.00 21,936.00
2 Nutrition & Health Solutions 3,134.00 5,960.00
3 Chemical Intermediates 5,156.00 9,553.00
Total Profit before tax 19,312.00 37,449.00
i. Finance cost 2,250.00 3,993.00
ii. Other Unallocable Expenditure net off Unallocable income 2,264.00 4,572.00
Profit before tax 14,798.00 28,884.00
3 (Segment Asset - Segment Liabilities)
Segment Asset
1 Speciality Chemicals 3,22,235.00 3,22,235.00
2 Nutrition & Health Solutions 86,868.00 86,868.00
3 Chemical Intermediates 1,59,382.00 1,59,382.00
Total Segment Asset 5,68,485.00 5,68,485.00
Un-allocable Assets 31,418.00 31,418.00
Net Segment Asset 5,99,903.00 5,99,903.00
4 Segment Liabilities
Segment Liabilities
1 Speciality Chemicals 90,780.00 90,780.00
2 Nutrition & Health Solutions 16,460.00 16,460.00
3 Chemical Intermediates 55,323.00 55,323.00
Total Segment Liabilities 1,62,563.00 1,62,563.00
Un-allocable Liabilities 1,05,700.00 1,05,700.00
Net Segment Liabilities 2,68,263.00 2,68,263.00
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2026 01-04-2026
B Date of end of reporting period 30-09-2026 30-09-2026
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Consolidated Consolidated
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 a) Items that will not be reclassified to profit or loss (449.00) (175.00)
Total Amount of items that will not be reclassified to profit and loss (449.00) (175.00)
2 Income tax relating to items that will not be reclassified to profit or loss (115.00) (74.00)
3 Amount of items that will be reclassified to profit and loss
1 a) Items that will be reclassified to profit or loss 80.00 256.00
Total Amount of items that will be reclassified to profit and loss 80.00 256.00
4 Income tax relating to items that will be reclassified to profit or loss (84.00) (181.00)
5 Total Other comprehensive income (170.00) 336.00



Cash flow statement, indirect

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2026
B Date of end of reporting period 30-09-2026
C Whether results are audited or unaudited Unaudited
D Nature of report standalone or consolidated Consolidated
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 28,890.00
Adjustments for reconcile profit (loss)
Adjustments for finance costs 3,993.00
Adjustments for decrease (increase) in inventories (20,369.00)
Adjustments for decrease (increase) in trade receivables, current (12,395.00)
Adjustments for decrease (increase) in trade receivables, non-current 0.00
Adjustments for decrease (increase) in other current assets 0.00
Adjustments for decrease (increase) in other non-current assets 0.00
Adjustments for other financial assets, non-current (4,842.00)
Adjustments for other financial assets, current 0.00
Adjustments for other bank balances 0.00
Adjustments for increase (decrease) in trade payables, current 15,640.00
Adjustments for increase (decrease) in trade payables, non-current 0.00
Adjustments for increase (decrease) in other current liabilities 584.00
Adjustments for increase (decrease) in other non-current liabilities 0.00
Adjustments for depreciation and amortisation expense 10,194.00
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0.00
Adjustments for provisions, current 0.00
Adjustments for provisions, non-current 0.00
Adjustments for other financial liabilities, current 0.00
Adjustments for other financial liabilities, non-current 0.00
Adjustments for unrealised foreign exchange losses gains (167.00)
Adjustments for dividend income 0.00
Adjustments for interest income 105.00
Adjustments for share-based payments 900.00
Adjustments for fair value losses (gains) 0.00
Adjustments for undistributed profits of associates 0.00
Other adjustments for which cash effects are investing or financing cash flow 0.00
Other adjustments to reconcile profit (loss) 0.00
Other adjustments for non-cash items 475.00
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0.00
Total adjustments for reconcile profit (loss) (6,092.00)
Net cash flows from (used in) operations 22,798.00
Dividends received 0.00
Interest paid 0.00
Interest received 0.00
Income taxes paid (refund) 4,663.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) operating activities 18,135.00
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0.00
Cash flows used in obtaining control of subsidiaries or other businesses 0.00
Other cash receipts from sales of equity or debt instruments of other entities 0.00
Other cash payments to acquire equity or debt instruments of other entities 117.00
Other cash receipts from sales of interests in joint ventures 0.00
Other cash payments to acquire interests in joint ventures 0.00
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0.00
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0.00
Proceeds from sales of property, plant and equipment 307.00
Purchase of property, plant and equipment 16,098.00
Proceeds from sales of investment property 0.00
Purchase of investment property 0.00
Proceeds from sales of intangible assets 0.00
Purchase of intangible assets 0.00
Proceeds from sales of intangible assets under development 0.00
Purchase of intangible assets under development 0.00
Proceeds from sales of goodwill 0.00
Purchase of goodwill 0.00
Proceeds from biological assets other than bearer plants 0.00
Purchase of biological assets other than bearer plants 0.00
Proceeds from government grants 0.00
Proceeds from sales of other long-term assets 0.00
Purchase of other long-term assets 0.00
Cash advances and loans made to other parties 3,000.00
Cash receipts from repayment of advances and loans made to other parties 0.00
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0.00
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0.00
Dividends received 0.00
Interest received 79.00
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash (21.00)
Net cash flows from (used in) investing activities (18,850.00)
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0.00
Payments from changes in ownership interests in subsidiaries 0.00
Proceeds from issuing shares 0.00
Proceeds from issuing other equity instruments 0.00
Payments to acquire or redeem entity's shares 0.00
Payments of other equity instruments 0.00
Proceeds from exercise of stock options 0.00
Proceeds from issuing debentures notes bonds etc 0.00
Proceeds from borrowings 15,594.00
Repayments of borrowings 5,218.00
Payments of lease liabilities 209.00
Dividends paid 3,927.00
Interest paid 4,559.00
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) financing activities 1,681.00
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes 966.00
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 256.00
Net increase (decrease) in cash and cash equivalents 1,222.00
Cash and cash equivalents cash flow statement at beginning of period 18,847.00
Cash and cash equivalents cash flow statement at end of period 20,069.00